{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-23-005359","form_type":"8-K","ticker":"AGPU","cik":"0001446159","company_name":"Axe Compute Inc.","filed_at":"2023-08-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.962107+00:00","generated_at":"2026-06-11T07:38:17.228521+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"medium","headline":"Predictive Oncology CFO Bob Myers to resign Sept 30; Josh Blacher named Interim CFO","bullets":["CFO Bob Myers notified resignation effective September 30, 2023, after nearly 12 years of service.","Company entered consulting agreement with Danforth Advisors for interim CFO services.","Josh Blacher of Danforth appointed Interim CFO; will serve as principal financial and accounting officer post-Transition Date.","Blacher is Managing Partner at Columbus Circle Capital and has prior CFO roles at Galmed, Therapix, and Inmed Pharmaceuticals."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-23-005359","json":"https://secwatch.observer/filing/0001171843-23-005359.json","markdown":"https://secwatch.observer/filing/0001171843-23-005359.md","text":"https://secwatch.observer/filing/0001171843-23-005359.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1446159/000117184323005359/0001171843-23-005359-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1446159/000117184323005359/f8k_081723.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T07:38:17.228521+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2fd9c25df4","claim":"Josh Blacher was named as Interim Chief Financial Officer at Axe Compute Inc..","evidence_excerpt":"Josh Blacher of Danforth, an experienced biotech executive who specializes in strategic finance and corporate development, has been named as the Company’s Interim Chief Financial Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1446159/000117184323005359/0001171843-23-005359-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"named"},{"label":"Role","value":"Interim Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"aec3956fb3","claim":"Bob Myers resigned as Chief Financial Officer, Corporate Secretary and Compliance Officer at Axe Compute Inc..","evidence_excerpt":"Bob Myers, the Chief Financial Officer, Corporate Secretary and Compliance Officer of Predictive Oncology Inc. (the \"Company\"), notified the Company of his intent to resign from the Company effective September 30, 2023 (the \"Transition Date\").","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1446159/000117184323005359/0001171843-23-005359-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Financial Officer, Corporate Secretary and Compliance Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}